In vitro α-interferon treatment of peripheral blood mononuclear cells improves interleukin-2 activity in HBV-related chronic liver disease
- 1 January 1985
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 1 (4), 385-393
- https://doi.org/10.1016/s0168-8278(85)80776-5
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptorsCellular Immunology, 1983
- Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture.Journal of Clinical Investigation, 1982
- T cell subsets in patients with acute and chronic HBV infection, primary biliary cirrhosis and alcohol induced liver diseaseInternational Journal of Immunopharmacology, 1981
- Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene.The Journal of Experimental Medicine, 1981
- Augmentation of human monocyte-mediated cytolysis by interferonCellular Immunology, 1980
- Long term culture of tumour-specific cytotoxic T cellsNature, 1977
- Effects of interferon preparations on rabbit corneal xenograftArchiv für die gesamte Virusforschung, 1977
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976
- Immunological aspects of hepatitis B virus infectionThe American Journal of the Medical Sciences, 1975
- INADEQUATE ANTIBODY RESPONSE TO HBAg OR SUPPRESSOR T-CELL DEFECT IN DEVELOPMENT OF ACTIVE CHRONIC HEPATITISThe Lancet, 1974